Literature DB >> 11727405

Oral therapies for diabetic hyperglycemia.

H E Lebovitz1.   

Abstract

Many classes of oral antihyperglycemic agents are available for the treatment of type 2 diabetic patients. These classes improve glucose metabolism by different mechanisms, and their effects are additive. Therapy with lifestyle modification and a single oral antihyperglycemic agent infrequently achieves target glycemic goals, and, if it does, the effect is usually not sustained. A more rational approach would seem to be therapy with combinations of drugs with different mechanisms of action. Initial therapy might be with submaximal concentrations of two drugs. As the diabetic abnormalities progress, maximal concentrations of the drugs and addition of other classes of oral agents or insulin may be needed to maintain the target glycemic goal. In choosing combinations of oral antihyperglycemic agents, their effects on the components treatment of type 2 diabetic patients. These classes improve glucose considered, as must the specific effects of the agents on glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11727405     DOI: 10.1016/s0889-8529(05)70221-8

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  14 in total

Review 1.  Treatment of the metabolic disturbances caused by antipsychotic drugs: focus on potential drug interactions.

Authors:  Trino Baptista; N M K Ng Ying Kin; Serge Beaulieu
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 2.  Pharmacokinetic interactions with thiazolidinediones.

Authors:  André J Scheen
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 3.  Sulfonylureas: a new look at old therapy.

Authors:  Peter M Thulé; Guillermo Umpierrez
Journal:  Curr Diab Rep       Date:  2014-04       Impact factor: 4.810

Review 4.  Oral antihyperglycemic therapy for type 2 diabetes mellitus.

Authors:  Alice Y Y Cheng; I George Fantus
Journal:  CMAJ       Date:  2005-01-18       Impact factor: 8.262

Review 5.  Current therapeutic options in type 2 diabetes mellitus: a practical approach.

Authors:  Michael T Sheehan
Journal:  Clin Med Res       Date:  2003-07

6.  Succinic acid monoethyl ester, a novel insulinotropic agent: effect on lipid composition and lipid peroxidation in streptozotocin-nicotin-amide induced type 2 diabetic rats.

Authors:  Ramalingam Saravanan; Leelavinothan Pari
Journal:  Mol Cell Biochem       Date:  2006-09-28       Impact factor: 3.396

7.  The incremental costs of recommended therapy versus real world therapy in type 2 diabetes patients.

Authors:  C Crivera; D C Suh; E S Huang; E Cagliero; R W Grant; L Vo; H C Shin; J B Meigs
Journal:  Curr Med Res Opin       Date:  2006-11       Impact factor: 2.580

Review 8.  Is there a role for alpha-glucosidase inhibitors in the prevention of type 2 diabetes mellitus?

Authors:  André J Scheen
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 9.  Current management strategies for coexisting diabetes mellitus and obesity.

Authors:  Andre J Scheen
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 10.  Drug therapy in transplant recipients: special considerations in the elderly with comorbid conditions.

Authors:  José F Bernardo; Jerry McCauley
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.